Market News
Stay updated with the latest market trends, earnings, and economic indicators.

Bank of Baroda, Cipla, RIL, HDFC AMC Dividend Record Date: Last Day To Buy Shares To Qualify
Dividend Record Date: Last Day To Buy Shares To Qualify
Cipla Share Price Live Updates: Cipla's beta indicates lower risk profile
Cipla Share Price Live Updates: Cipla's Recent Trading Activity
Cipla Share Price Live Updates: Cipla's Daily Performance Update

Dividend, Bonus Issues This Week: RIL, Trent, Cipla, Ashok Leyland And More
Trent Ltd has fixed June 4 as the record date for a 1:2 bonus issue.

Dividend, stock split, buybacks this week: Wipro, RIL, Cipla, Trent, Ashok Leyland, JSW Energy, among others in focus - Upstox
Dividend, stock split, buybacks this week: Wipro, RIL, Cipla, Trent, Ashok Leyland, JSW Energy, among others in focusUpstox

Cipla to meet investors at Citi India Conference on June 5 - scanx.trade
Cipla to meet investors at Citi India Conference on June 5scanx.trade
Cipla is aiming for 40-50 global product filings in three years, says MD Achin Gupta
Cipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant global product filings over the next three years. Cipla will also expand its presence in North America and Europe. Innovation is expected to contribute a meaningful portion of revenues in the coming decade.
Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEO
As Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to broaden its footprint in North America and Europe through sophisticated product offerings, Cipla is also intensifying its focus on managing chronic conditions such as diabetes and heart diseases in India.